Search Within

Juliann Chmielecki

Formats
  1. Meeting Abstract (7)
  2. Journal Article (5)
Groups
  1. Department of Pathology and Laboratory Medicine (10)
  2. GSK Faculty (7)
  3. Human Oncology and Pathogenesis Program (5)
  4. Sloan Kettering Institute Postdocs (5)
  5. Tow Center for Developmental Oncology (TCDO) (5)
  6. Department of Medicine (4)

More Groups

People
  1. William Pao (6)
  2. Marc Ladanyi (5)
  3. Lu Wang (4)
  4. Vincent Miller (4)
  5. Romel Somwar (3)
  6. Ahmet Zehir (2)

More People

Years
  1. 2015 (4)
  2. 2012 (1)
  3. 2011 (2)
  4. 2009 (3)
  5. 2007 (2)
Publications
  1. Cancer Research (2)
  2. Clinical Cancer Research (2)
  3. Laboratory Investigation (2)
  4. Modern Pathology (2)
  5. Genes Chromosomes and Cancer (1)
  6. Molecular Cancer Therapeutics (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. Nature Publishing Group (2)
  3. Nature Research (2)
  4. National Academy of Sciences (1)
  5. Public Library of Science (1)
  6. Wiley Periodicals, Inc (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reliable detection of ALK gene fusions in lung cancers by hybrid capture-based next-generation sequencing: High concordance with ALK FISH and ALK IHC
    Meeting Abstract

    Yelensky, R.; Donahue, A.; Chalmers, Z.; Otto, G.; Nahas, M.; He, J.; Juhn, F.; Frampton, G.; Chmielecki, J.; Ross, J.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Reliable detection of ALK gene fusions in lung cancers by hybrid capture-based next-generation sequencing: High concordance with ALK FISH and ALK IHC
    Meeting Abstract

    Yelensky, R.; Donahue, A.; Chalmers, Z.; Otto, G.; Nahas, M.; He, J.; Juhn, F.; Frampton, G.; Chmielecki, J.; Ross, J.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Development of BRAF FISH assay for the detection of BRAF gene rearrangements identified in pancreatic acinar cell carcinomas
    Meeting Abstract

    Wang, L.; Basturk, O.; Chmielecki, J.; Ross, J.; Stephens, P.; Adsay, V.; Askan, G.; Klimstra, D.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Development of BRAF FISH assay for the detection of BRAF gene rearrangements identified in pancreatic acinar cell carcinomas
    Meeting Abstract

    Wang, L.; Basturk, O.; Chmielecki, J.; Ross, J.; Stephens, P.; Adsay, V.; Askan, G.; Klimstra, D.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm
    Journal Article

    Chmielecki, J.; Peifer, M.; Viale, A.; Hutchinson, K.; Giltnane, J.; Socci, N. D.; Hollis, C. J.; Dean, R. S.; Yenamandra, A.; Jagasia, M.; more...
    Genes Chromosomes and Cancer (2012)

    Fulltext@MSK | Save
  • New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosinekinase inhibitors in lung cancer
    Journal Article

    Oxnard, G. R.; Arcila, M. E.; Chmielecki, J.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
    Journal Article

    Oxnard, G. R.; Arcila, M. E.; Sima, C. S.; Riely, G. J.; Chmielecki, J.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • A computational approach to optimize dosing strategies for EGFR tyrosine kinase inhibitors in EGFR mutant lung adenocarcinoma
    Meeting Abstract

    Foo, J.; Chmielecki, J.; Pao, W.; Michor, F.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • EGFR T790M decreases growth potential of lung tumor cells with drug-sensitive EGFR mutant alleles in the absence of drug selection
    Meeting Abstract

    Chmielecki, J.; Foo, J.; Somwar, R.; Regales, L.; Vivanco, I.; Shen, R.; Michor, F.; Pao, W.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
    Journal Article

    Veeriah, S.; Brennan, C.; Meng, S.; Singh, B.; Fagin, J. A.; Solit, D. B.; Paty, P. B.; Rohle, D.; Vivanco, I.; Chmielecki, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save